Loring Wolcott & Coolidge Fiduciary Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-100
| Closed | -$18K | – | 678 |
|
|
2020
Q1 | $18K | Sell |
100
-175
| -64% | -$31.5K | ﹤0.01% | 481 |
|
|
2019
Q4 | $53K | Hold |
275
| – | – | ﹤0.01% | 415 |
|
|
2019
Q3 | $46K | Sell |
275
-35
| -11% | -$5.86K | ﹤0.01% | 416 |
|
|
2019
Q2 | $52K | Hold |
310
| – | – | ﹤0.01% | 402 |
|
|
2019
Q1 | $45K | Hold |
310
| – | – | ﹤0.01% | 411 |
|
|
2018
Q4 | $41K | Sell |
310
-219
| -41% | -$29K | ﹤0.01% | 435 |
|
|
2018
Q3 | $101K | Sell |
529
-989
| -65% | -$189K | ﹤0.01% | 349 |
|
|
2018
Q2 | $253K | Buy |
1,518
+394
| +35% | +$65.7K | ﹤0.01% | 252 |
|
|
2018
Q1 | $189K | Buy |
1,124
+989
| +733% | +$166K | ﹤0.01% | 281 |
|
|
2017
Q4 | $22K | Sell |
135
-2,272
| -94% | -$370K | ﹤0.01% | 513 |
|
|
2017
Q3 | $493K | Sell |
2,407
-13
| -0.5% | -$2.66K | 0.01% | 196 |
|
|
2017
Q2 | $611K | Buy |
2,420
+13
| +0.5% | +$3.28K | 0.01% | 183 |
|
|
2017
Q1 | $575K | Sell |
2,407
-24
| -1% | -$5.73K | 0.01% | 185 |
|
|
2016
Q4 | $511K | Sell |
2,431
-1,065
| -30% | -$224K | 0.01% | 189 |
|
|
2016
Q3 | $805K | Buy |
3,496
+964
| +38% | +$222K | 0.02% | 162 |
|
|
2016
Q2 | $585K | Buy |
2,532
+85
| +3% | +$19.6K | 0.01% | 177 |
|
|
2016
Q1 | $656K | Sell |
2,447
-14
| -0.6% | -$3.75K | 0.02% | 166 |
|
|
2015
Q4 | $769K | Sell |
2,461
-3
| -0.1% | -$937 | 0.02% | 168 |
|
|
2015
Q3 | $748K | Hold |
2,464
| – | – | 0.02% | 171 |
|
|
2015
Q2 | $748K | Sell |
2,464
-13
| -0.5% | -$3.95K | 0.02% | 171 |
|
|
2015
Q1 | $737K | Buy |
2,477
+2,268
| +1,085% | +$675K | 0.02% | 174 |
|
|
2014
Q4 | $54K | Sell |
209
-5
| -2% | -$1.29K | ﹤0.01% | 419 |
|
|
2014
Q3 | $52K | Sell |
214
-86
| -29% | -$20.9K | ﹤0.01% | 407 |
|
|
2014
Q2 | $67K | Hold |
300
| – | – | ﹤0.01% | 404 |
|
|
2014
Q1 | $62K | Buy |
+300
| New | +$62K | ﹤0.01% | 394 |
|